Published in Healthcare Finance, Tax and Law Weekly, August 15th, 2007
Revenues for the three months ended June 30, 2007 were $2.3 million, up from $210,000 from the corresponding period in 2006. The increase was due to two factors: improvements in cost recovery from Insmed's Expanded Access Program (EAP) to treat patients with amyotrophic lateral sclerosis (ALS) and the receipt of licensing income...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.